Tags

Type your tag names separated by a space and hit enter

[Indications and contraindications for epididymo-deferens vesiculography from a current viewpoint].
Rofo. 1983 Jun; 138(6):736-9.ROFO

Abstract

69 years after the introduction of x-ray examination of the seminal duct, the indication and contraindication are reviewed according to current interdisciplinary aspects, basing on 31 cases studied over a period of two years. The procedure followed in the roentgenological visualization of carcinoma of the prostate is generally recognized, whereas controversial opinions are held with regard to patients with occlusive azoospermia. The possibility of lesions and damage caused by some contrast media is an established fact. Differences in the lumen of the ductus epididymidis prevented complete visualization of the epididymis when using the previous, highly concentrated, sticky contrast media which were insoluble in water. These drawbacks have been eliminated by Amipaque. Today epididymograms are no longer considered necessary, although there are exceptions. Experience and a sophisticated technique are mandatory. If refertilization is envisaged, it is permissible during operation only to effect a descending x-ray for the purpose of clarifying the outflow conditions.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

ger

PubMed ID

6407938

Citation

Drawz, G, et al. "[Indications and Contraindications for Epididymo-deferens Vesiculography From a Current Viewpoint]." RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, vol. 138, no. 6, 1983, pp. 736-9.
Drawz G, Heise H, Drawz B, et al. [Indications and contraindications for epididymo-deferens vesiculography from a current viewpoint]. Rofo. 1983;138(6):736-9.
Drawz, G., Heise, H., Drawz, B., Jentzen, H., & Hoffmann, L. (1983). [Indications and contraindications for epididymo-deferens vesiculography from a current viewpoint]. RoFo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin, 138(6), 736-9.
Drawz G, et al. [Indications and Contraindications for Epididymo-deferens Vesiculography From a Current Viewpoint]. Rofo. 1983;138(6):736-9. PubMed PMID: 6407938.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Indications and contraindications for epididymo-deferens vesiculography from a current viewpoint]. AU - Drawz,G, AU - Heise,H, AU - Drawz,B, AU - Jentzen,H, AU - Hoffmann,L, PY - 1983/6/1/pubmed PY - 1983/6/1/medline PY - 1983/6/1/entrez SP - 736 EP - 9 JF - RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin JO - Rofo VL - 138 IS - 6 N2 - 69 years after the introduction of x-ray examination of the seminal duct, the indication and contraindication are reviewed according to current interdisciplinary aspects, basing on 31 cases studied over a period of two years. The procedure followed in the roentgenological visualization of carcinoma of the prostate is generally recognized, whereas controversial opinions are held with regard to patients with occlusive azoospermia. The possibility of lesions and damage caused by some contrast media is an established fact. Differences in the lumen of the ductus epididymidis prevented complete visualization of the epididymis when using the previous, highly concentrated, sticky contrast media which were insoluble in water. These drawbacks have been eliminated by Amipaque. Today epididymograms are no longer considered necessary, although there are exceptions. Experience and a sophisticated technique are mandatory. If refertilization is envisaged, it is permissible during operation only to effect a descending x-ray for the purpose of clarifying the outflow conditions. SN - 1438-9029 UR - https://www.unboundmedicine.com/medline/citation/6407938/[Indications_and_contraindications_for_epididymo_deferens_vesiculography_from_a_current_viewpoint]_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1055819 DB - PRIME DP - Unbound Medicine ER -